[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337632-105":59,"doc-detail-337632-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","comprehensive-mutational-scanning-of-egfr-reveals-tki-sensitivities-of-extracellular-domain-mutants","Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants","","The article presents a comprehensive functional analysis of EGFR mutations, focusing on how extracellular domain variants influence sensitivity to EGFR tyrosine kinase inhibitors. Saturation mutagenesis was performed, assessing ~22,500 EGFR variants in an EGFR-dependent lung cancer cell line, which identifies erlotinib-insensitive enrichment across dimerization, transmembrane, and kinase regions. Several extracellular domain variants, not tied to approved targeted therapies, show in vitro sensitivity to afatinib and dacomitinib, and clinical observations are discussed for glioblastoma.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/comprehensive-mutational-scanning-of-egfr-reveals-tki-sensitivities-of-extracellular-domain-mutants/337632/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/comprehensive-mutational-scanning-of-egfr-reveals-tki-sensitivities-of-extracellular-domain-mutants/337632.png","ImageObject",300,407,{"name":92,"@type":93},"Olivia Brown","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What experimental approach was used to evaluate EGFR mutations?","Question",{"text":113,"@type":114},"The study used saturation mutagenesis of EGFR and assessed function of about 22,500 variants in a human EGFR-dependent lung cancer cell line.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which EGFR inhibitors were tested for extracellular domain mutants?",{"text":118,"@type":114},"Multiple extracellular domain variants were tested in vitro for sensitivity to afatinib and dacomitinib.",{"name":120,"@type":111,"acceptedAnswer":121},"How did extracellular domain mutations relate to glioblastoma treatment response?",{"text":122,"@type":114},"Two glioblastoma patients with EGFR G598V dimerization domain mutations showed responses to dacomitinib, followed by within-pathway resistance mutation in one case.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},337632,1790183926,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Article [https://doi.org/10.1038/s41467-024-45594-4](https://doi.org/10.1038/s41467-024-45594-4)  \nComprehensive mutational scanning of EGFR revealsTKI sensitivities of extracellular domain mutants  \nReceived: 21 September 2023  \nAccepted: 30 January 2024  \n\n| Published online: 28 March 2024 |\n| --- |\n| Check for updates |\n\nTikvah K. Hayes1,2,10, Elisa Aquilanti1,2, Nicole S. Persky2,3,11, Xiaoping Yang 3, Erica E. Kim1, Lisa Brenan2, Amy B. Goodale3, Douglas Alan3, Ted Sharpe4, Robert E. Shue1,2, Lindsay Westlake2, Lior Golomb1,2, Brianna R. Silverman1, Myshal D. Morris5, Ty Running Fisher5, Eden Beyene5, Yvonne Y. Li 1,2, Andrew D. Cherniack 1,2, Federica Piccioni 3,12, J. Kevin Hicks6, Andrew S. Chi7, Daniel P. Cahill7, Jorg Dietrich8, Tracy T. Batchelor9, David E. Root 3,  \nCory M. Johannessen 2,13 & Matthew Meyerson 1,2   \nThe epidermal growth factor receptor, EGFR, is frequently activated in lung cancer and glioblastoma by genomic alterations including missense mutations. The different mutation spectra in these diseases are reﬂected in divergent responses to EGFR inhibition: signiﬁcant patient beneﬁt in lung cancer, but limited in glioblastoma. Here, we report a comprehensive mutational analysis of EGFR function. We perform saturation mutagenesis of EGFR and assess function of ~22,500 variants in a human EGFR-dependent lung cancer cell line. This approach reveals enrichment of erlotinib-insensitive variants of known and unknown signiﬁcance in the dimerization, transmembrane, and kinase domains. Multiple EGFR extracellular domain variants, not associated with approved targeted therapies, are sensitive to afatinib and dacomitinib in vitro. Two glioblastoma patients with somatic EGFR G598V dimerization domain mutations show responses to dacomitinib treatment followed by within-pathway resistance mutation in one case. In summary, this comprehensive screen expands the landscape of functional EGFR variants and suggests broader clinical investigation of EGFR inhibition for cancers harboring extracellular domain mutations.  \nThe epidermal growth factor receptor, or EGFR, is a transmembrane receptor tyrosine kinase (RTK), that like many other RTKs, is commonly mutated in cancer. EGFR alterations are observed in ~5% of all cancer patients, 14% of patients with non-small cell lung cancer, and 26% of patients with glioblastoma1–5. The use of targeted panel sequencing has helped identify multiple hotspot activating alterations in EGFR-mutant cancers, most notably missense mutations in EGFR at amino acids A289, G719, and L858, although activating alterations in EGFR can also include in-frame insertions and deletions, truncations, fusions, and ampliﬁcations6–8. When assessing  \nEGFR missense mutations, glioblastomas are generally characterized by extracellular domain mutations, while mutations in EGFR-mutant lung cancers generally arise in the kinase domain4,9,10. However, there are reciprocal examples where we ﬁnd EGFR extracellular domain mutations in lung cancer and kinase domain mutations in glioblastoma1,11,12. In addition to mutations that have been deﬁnitively characterized as oncogenic drivers, other subsets of EGFR missense mutations with unknown functional relevance have been, and continue to be, identiﬁed in patients. Variants with no reported function are classiﬁed as variants of unknown signiﬁcance (VUS),  \nA full list of afﬁliations appears at the end of the paper. [e-mail:](e-mail: matthew_meyerson@dfci.harvard.edu)[ matthew_meyerson@dfci.harvard.edu](e-mail: matthew_meyerson@dfci.harvard.edu)  \nwhile oncogenic drivers are classiﬁed as variants of known signiﬁcance (VKS) .  \nGiven the prevalence of patient-observed EGFR variants, several generations of EGFR tyrosine kinase inhibitors (TKIs) have been, and continue to be, developed13,14. Clinical response to EGFR TKIs has varied, where subsets ofEGFR variants, like L858, are sensitive to ﬁrstand third generation TKIs15–17, while uncommon mutations (G719, S768, and L861) h","cbCaiaENlzZH89ii","https://ap.wps.com/l/cbCaiaENlzZH89ii","pdf",5585871,18,"English","# Background\n## EGFR alterations and clinical responses\n# Methods\n## Saturation mutagenesis and functional assessment\n# Results\n## Inhibitor sensitivity across EGFR domains\n## Extracellular domain variants and in vitro drug response\n## Glioblastoma patient observations\n# Conclusions","[{\"question\":\"What experimental approach was used to evaluate EGFR mutations?\",\"answer\":\"The study used saturation mutagenesis of EGFR and assessed function of about 22,500 variants in a human EGFR-dependent lung cancer cell line.\"},{\"question\":\"Which EGFR inhibitors were tested for extracellular domain mutants?\",\"answer\":\"Multiple extracellular domain variants were tested in vitro for sensitivity to afatinib and dacomitinib.\"},{\"question\":\"How did extracellular domain mutations relate to glioblastoma treatment response?\",\"answer\":\"Two glioblastoma patients with EGFR G598V dimerization domain mutations showed responses to dacomitinib, followed by within-pathway resistance mutation in one case.\"}]","Comprehensive mutational scanning of EGFR reveals TKI sensitivities of extracellular domain mutants | PDF",1790019898,45,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/db35715afb48a093d2797d337ee0db45.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/71e73a5e9a8e0e24b6ef4076f00771ff.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8a409d562fd4513b2eb43f7793abb4b2.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ef45c05a6d64a7082e15a19ef3bbdc00.webp",980,1301]